NIH bolstering Leverage recent NIH P01 grant to position Intralytix as a federally supported innovator with potential for expanded research collaborations, contract research, and funded pilot programs in phage-based solutions.

Strategic partnerships Capitalize on past and ongoing collaborations with Lesaffre Yeast, AB Agri, and other partners to identify co-development or licensing opportunities for phage products in animal feed, food safety, and environmental applications.

Phage focus Highlight proprietary bacteriophage platforms targeting foodborne pathogens and environmental bacteria to target customers in food processing, healthcare settings, and environmental services seeking non-antibiotic solutions.

Funding readiness With multimillion-dollar grant success and a mid-range revenue profile, pursue value-based partnerships, grant-backed pilots, and milestone-driven deals with mid- to large-cap biotech, agriculture, and food players.

Growth readiness Target mid-market food producers, processing facilities, and environmental services companies actively seeking phage-based controls; emphasize scalability, regulatory progress, and a path to broader commercial adoption.